TransMedics (TMDX) Gains from Sales and Divestitures (2024 - 2025)
TransMedics (TMDX) recorded quarterly Gains from Sales and Divestitures of $1280.0 in Q4 2025, down 91.56% quarter-over-quarter from $15157.0 in Q3 2025, and up 101.24% on a YoY basis from $636.06 in Q4 2024.
TransMedics (TMDX) Gains from Sales and Divestitures (2024 - 2025) Analysis & Trends
TransMedics' Gains from Sales and Divestitures history runs 2 years deep, the most recent figure standing at $1280.0 for Q4 2025.
- In Q4 2025, Gains from Sales and Divestitures rose 101.24% year-over-year to $1280.0; the TTM figure through Dec 2025 stood at $1280.0 (up 101.24% YoY), while the FY2025 annual figure was $1280.0, up 101.24% from the prior year.
- Gains from Sales and Divestitures was $1280.0 for Q4 2025 at TransMedics, down from $15157.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $111419.0 in Q1 2025 to a low of -$103372.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | TransMedics | 2.72 Bn | 2.26 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,280.00 |
| Dec 31, 2025 | 1,280.00 |
| Sep 30, 2025 | 15,157.00 |
| Sep 30, 2025 | 15,157.00 |
| Jun 30, 2025 | 18,893.00 |
| Jun 30, 2025 | 18,893.00 |
| Mar 31, 2025 | 111,419.00 |
| Mar 31, 2025 | 111,419.00 |
| Dec 31, 2024 | -103,372.00 |
| Dec 31, 2024 | -103,372.00 |
| Sep 30, 2024 | 15,004.00 |
| Sep 30, 2024 | 15,004.00 |
| Jun 30, 2024 | 17,772.00 |
| Jun 30, 2024 | 17,772.00 |
| Mar 31, 2024 | 58,044.00 |
| Mar 31, 2024 | 58,044.00 |